Results 101 to 110 of about 923 (130)
Identification of lead inhibitors for 3CLpro of SARS-CoV-2 target using machine learning based virtual screening, ADMET analysis, molecular docking and molecular dynamics simulations. [PDF]
RSC AdvChhetri SP +3 more
europepmc +1 more source
Development and validation of a nomogram to assess the occurrence of liver dysfunction in patients with COVID-19 pneumonia in the ICU. [PDF]
BMC Infect DisWang Z, Zhao L, Xie K.
europepmc +1 more source
Comparative Analysis of Viral Load Quantification Using Reverse Transcription Polymerase Chain Reaction and Digital Droplet Polymerase Chain Reaction. [PDF]
Int J Mol SciGebe Abreu Cabral P +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Azvudine versus Paxlovid in COVID‐19: A systematic review and meta‐analysis
Reviews in Medical VirologyThis systematic review and meta‐analysis aimed to compare the effectiveness and safety of azvudine versus nirmatrelvir/ritonavir (Paxlovid) in treating coronavirus disease 2019 (COVID‐19).
Behnam Amani, Bahman Amani
semanticscholar +3 more sources
International Journal of Molecular SciencesAzvudine (FNC) is a novel cytidine analogue that is widely used in the treatment of infectious diseases such as AIDS and COVID-19. Previous studies have demonstrated its anticancer activity in various cancer cell lines, including non-Hodgkin’s lymphomas ...
Yao Meng +10 more
semanticscholar +2 more sources
Langmuir
Azvudine (FNC) is a dual-target inhibitor of HIV reverse transcriptase and accessory protein Vif, which can effectively inhibit the reverse transcription and replication of the HIV virus in vivo and can also be used for the treatment of novel coronavirus
Qi Wang +5 more
semanticscholar +3 more sources
Azvudine (FNC) is a dual-target inhibitor of HIV reverse transcriptase and accessory protein Vif, which can effectively inhibit the reverse transcription and replication of the HIV virus in vivo and can also be used for the treatment of novel coronavirus
Qi Wang +5 more
semanticscholar +3 more sources
Azvudine and mortality in patients with coronavirus disease 2019: A retrospective cohort study
International Immunopharmacology, 2023Several studies have found that azvudine (FNC) can inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication both in vivo and in vitro. However, the effect of FNC on the risk of death in patients with coronavirus disease 2019 (COVID-19) is unclear.
Bin Liu +7 more
openaire +2 more sources
A Nearly
Comprehensive SummaryModified nucleosides, particularly those with 4'‐modifications, are significant nucleosides used in antiviral treatments. The drug discovery campaign of Azvudine starts from 2′‐deoxynucleoside, followed by extensive modifications, such as introducing the 4’‐position substitutions, a 2’‐β‐fluoro atom, and changing the nucleobases ...
Bin Yu, Junbiao Chang
openaire +1 more source
Journal of Medical Virology, 2023
Chinese guidelines prioritize the use of Azvudine and nirmatrelvir–ritonavir in COVID‐19 patients. Nevertheless, the real‐world effectiveness of Azvudine versus nirmatrelvir–ritonavir is still lacking, despite clinical trials showing their effectiveness ...
Guangtong Deng +11 more
semanticscholar +1 more source
Chinese guidelines prioritize the use of Azvudine and nirmatrelvir–ritonavir in COVID‐19 patients. Nevertheless, the real‐world effectiveness of Azvudine versus nirmatrelvir–ritonavir is still lacking, despite clinical trials showing their effectiveness ...
Guangtong Deng +11 more
semanticscholar +1 more source